Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Long-Term Deferred Tax: 2010-2025

Historic Long-Term Deferred Tax for China Pharma Holdings (CPHI) over the last 1 years, with Sep 2025 value amounting to $22.7 million.

  • China Pharma Holdings' Long-Term Deferred Tax was N/A to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.7 million, marking a year-over-year change of. This contributed to the annual value of $21.7 million for FY2024, which is 0.78% up from last year.
  • As of Q3 2025, China Pharma Holdings' Long-Term Deferred Tax stood at $22.7 million, which was up 2.71% from $22.1 million recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Long-Term Deferred Tax ranged from a high of $24.0 million in Q4 2021 and a low of $21.5 million during Q4 2023.
  • Over the past 3 years, China Pharma Holdings' median Long-Term Deferred Tax value was $21.9 million (recorded in 2025), while the average stood at $22.0 million.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first decreased by 13.32% in 2021, then climbed by 0.78% in 2024.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Long-Term Deferred Tax stood at $24.0 million in 2021, then declined by 8.33% to $22.0 million in 2022, then dropped by 2.07% to $21.5 million in 2023, then increased by 0.78% to $21.7 million in 2024, then reached $22.7 million in 2025.
  • Its Long-Term Deferred Tax was $22.7 million in Q3 2025, compared to $22.1 million in Q2 2025 and $21.9 million in Q1 2025.